CNBT
ALXN

Canandaigua National Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Canandaigua National Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$244K Buy
2,712
+616
+29% +$60.5K 0.05% 214
2019
Q4 		$227K Sell
2,096
-974
-32% -$104K 0.04% 241
2019
Q3 		$301K Buy
3,070
+25
+0.8% +$2.82K 0.05% 214
2019
Q2 		$399K Buy
3,045
+49
+2% +$6.32K 0.07% 184
2019
Q1 		$405K Buy
2,996
+334
+13% +$41.5K 0.08% 176
2018
Q4 		$259K Buy
+2,662
New +$315K 0.05% 232

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canandaigua National Bank & Trust's ALXN Position: Q1 2020 in Review

Canandaigua National Bank & Trust increased its Alexion Pharmaceuticals (ALXN) stake by 29% in Q1 2020, buying an estimated $60.5K and bringing the position to 2,712 shares worth $244K. The position accounts for 0.05% of the portfolio, ranked #214.

Canandaigua National Bank & Trust first reported a position in ALXN in Q4 2018 and has held it in 6 quarters since. The position peaked at $405K in Q1 2019. 654 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • Canandaigua National Bank & Trust held 2,712 shares of Alexion Pharmaceuticals worth $244K as of Q1 2020.
  • Canandaigua National Bank & Trust bought 616 Alexion Pharmaceuticals shares in Q1 2020, an estimated $60.5K.
  • Alexion Pharmaceuticals made up 0.05% of Canandaigua National Bank & Trust's portfolio in Q1 2020, its #214 holding.
  • Canandaigua National Bank & Trust first reported a position in Alexion Pharmaceuticals in Q4 2018 and has held it in 6 quarters since.
  • Canandaigua National Bank & Trust's Alexion Pharmaceuticals position peaked at $405K in Q1 2019.
  • 654 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Canandaigua National Bank & Trust's 13F filing for Q1 2020, filed 16 Apr 2020.